To date, we have provided cell and gene therapy access to more than 500 patients globally via Expanded Access mechanisms https://lnkd.in/e5uUJpbB #CellAndGene #CGTx #UnipharCellAndGene #UnipharAccess #Uniphar #GoToMarketStrategy #ExpandedAccess
Uniphar | Access
Pharmaceutical Manufacturing
Uniphar Access is a leading specialist pharmaceutical supplier shipping to over 160 countries.
About us
Uniphar is a respected global partner to pharma, biotech and medtech manufacturers working to improve patient access to medicines in Europe and around the world. Uniphar | Access is part of the Uniphar Pharma division, a trusted partner to unlock access to innovative therapies and optimise value for brands globally. Our History One of the world’s leading specialist medical suppliers with a 50-year history, Durbin was bought by Uniphar plc in 2019. With offices and warehousing in the UK, Europe and USA, we pride ourselves on being a trusted global partner to healthcare manufacturers and can supply products from source covering everything from a single cold chain item to large scale humanitarian projects. We are fully licensed by the UK MHRA, USA Pharmacy Authorities and DEA. Exclusive Access Services Our Expanded Access business will now operate under our parent brand, Uniphar. What we can help you with: • Running programs for pharmaceutical and biotech companies on a compassionate and named patient basis. • Clinical Trials Supply – supplying comparators for pharmaceutical companies both directly and via third parties. On-Demand Access Services Our On Demand Access services are retaining the Durbin name for the moment. To learn more log onto www.durbinglobal.com What we can help you with: • International Sales – supplying branded and generic pharmaceuticals to healthcare professionals around the world. • UK Imports – supplying UK hospitals with unlicensed medicines, out of stock solutions and regulatory support. • Sexual Health Supplies – supplying reversible contraceptives and equipment to healthcare professionals in the UK. • Third Party Distribution – storage, logistics and delivery tailored to your needs. • In addition, we supply pharmaceuticals, medical equipment and consumables to the Aid and Development sector for projects across the developing world.
- Website
-
https://uniphar.com/access/
External link for Uniphar | Access
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Co. Dublin
- Type
- Public Company
- Founded
- 1963
- Specialties
- Clinical Trials Supply, Managed Access Programs, International Sales, Sales to NGO's and Charities, Sexual Health Supplies, Third Party Distribution, Imports (Unlicenced Medicines), and Expanded Access Programs
Locations
-
Primary
Global Headquarters - 4045 Kingswood Road
Citywest Business Park
Co. Dublin, D24 VO6K, IE
-
Swallowfield Way
Hayes, England UB3 1DQ, GB
-
5820 Gulf Tech Dr
Ocean Springs, Mississippi 39564, US
Employees at Uniphar | Access
-
Dan Piggott
Managing Director, Exclusive Access at Uniphar
-
Jane Hill
Experienced Pharmaceutical industry Commercial manager with in depth experience in Brands, Generics, Biosimilars, launch of Specialty products…
-
Kelly Hopkins
Talent Acquisition Specialist at Durbin
-
Helen L. Small
Assistant Sales & Purchasing Executive at Durbin PLC
Updates
-
Dan Piggott, Managing Director, Exclusive Access at Uniphar, joined over 500 industry experts at the Alliance of Regenerative Medicine’s Meeting on the Med to discuss the fast-growing environment across the cell and gene therapy sector. Discover Dan's reflections on the event, with Pf Media. #CellAndGene #CGTx #UnipharAccess #Uniphar
-
We simplify expanded access programs, optimizing patient access to life changing therapies. We pride ourselves on transforming lives. https://lnkd.in/eKvqsEY9 #ExpandedAccess #ExpandedAccessProgram #UnipharAccess #Uniphar #GoToMarketStrategy
Uniphar Access - Uniphar Access
uniphar.com
-
Struggling to navigate regulatory complexities for expanded access? Contact our team for expertise, strategic partnerships, and execution excellence to ensure seamless delivery of critical therapies, including cell and gene therapies. https://lnkd.in/eKvqsEY9 #Uniphar #UnipharAccess #MarketAccess #GlobalAccess #CellAndGene #ExpandedAccess #ExpandedAccessProgram
Uniphar Access - Uniphar Access
uniphar.com
-
Today is the final day of the Cell and Gene Therapy Pricing and Reimbursement Summit. We have had some fantastic conversations over the past couple of days. Looking forward to reflecting on learnings from the sessions and panel discussions. #CellandGeneTherapy #PricingReimbursement #MarketAccess #ExpandedAccessProgram #ExpandedAccess
-
Hear from Tom Smith today, at 11.30am (EST) at the Cell and Gene Therapy Pricing and Reimbursement Summit. Tom will be discussing how Uniphar are accelerating global patient access to cell and gene therapies. #CellandGeneTherapy #PricingReimbursement #MarketAccess #ExpandedAccess
-
It is day one of the Cell and Gene Therapy Pricing and Reimbursement Summit agenda. Catch up with Tom Smith and Tharshan Umakanthan to find out how we can support you to build the optimum environment for cell and gene therapy assets in complex markets #CellandGeneTherapy #PricingReimbursement #MarketAccess #ExpandedAccess #ExpandedAccessProgram
-
We are delighted to announce the launch of Uniphar Cell and Gene Therapy. Our proprietary CGT platform allows us to streamline and optimize strategy from early access to commercialization and sustained market success. https://lnkd.in/ghKqQrjF #CellandGeneTherapy #MarketAccess #ExpandedAccess #UnipharCellandGene
-
Meet Tom Smith and Tharshan Umakanthan at the Cell and Gene Therapy Pricing and Reimbursement Summit to find out how Uniphar Cell and Gene Therapy can deliver tailored solutions that optimize patient access worldwide. #CellandGeneTherapy #PricingReimbursement #MarketAccess #EAP
-
We are driven to make access to cell and gene therapies available, regardless of who the patient is or where they live. Read our second whitepaper on equitable access. https://lnkd.in/eyafeZni #UnipharAccess #MarketAccess #GlobalAccess #CellAndGene #Uniphar